DJIA 17,066.18 87.05 0.51%
NASDAQ 4,533.09 6.61 0.15%
S&P 500 1,993.13 6.62 0.33%
market minute promo

30.31 -0.78 (-2.51%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AEGR $30.31 -2.51%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $31.17
Previous Close $31.09
Daily Range $30.20 - $31.80
52-Week Range $26.25 - $101.00
Market Cap $895.6M
P/E Ratio -17.77
Dividend (Yield) $0.00 (0.0%)
Volume 739,271
Average Daily Volume 1,268,944
Current FY EPS -$0.93

Sector

Healthcare

Industry

Drugs

Aegerion Pharmaceuticals, Inc. (AEGR) Description

Aegerion Pharmaceuticals, Inc. Website: http://www.aegerion.com/

News & Commentary

Why Investors Continue to Flee Aegerion Stock

In theory Aegerion could still reach this peaks sales figure (quite easily) given that there are many more reimbursable HoFH patients out there, but it appears that Amgen’s (AMGN) hugely successful PCSK9 inhibitor evolocumab will dethrone Juxtapid before that happens.

Insider Trading Alert - GBX, AEGR And ABG Traded By Insiders

Aegerion Pharmaceuticals Is Still Significantly Overvalued

Why Aegerion Pharmaceuticals (AEGR) Stock Is Down Today

The Long And Short Of It: Buy Insys Therapeutics And Sell GW Pharmaceuticals

Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR

Thursday 7/31 Insider Buying Report: AEGR, OCFC

Strength Seen in Aegerion Pharmaceuticals (AEGR): Stock Shoots up 16.4% - Tale of the Tape

Regeneron's Eylea Gets FDA Nod for Diabetic Macular Edema - Analyst Blog

Aegerion Q2 Loss Narrower than Expected, 2014 View Retained - Analyst Blog

Sector Update: Health Care Stocks Narrowly Mixed; Aegerion Pharma Climbing After Paring Q2 Net Loss,

Sector Update: Health Care Stocks Narrowly Mixed; Aegerion Pharma Climbing After Paring Q2 Net Loss, Crushing Estimates

See More AEGR News...

AEGR's Top Competitors

AEGR $30.31 (-2.51%)
Current stock: AEGR
JNJ $104.39 (1.14%)
Current stock: JNJ
NVS $89.01 (0.46%)
Current stock: NVS
RHHBY $36.45 (-0.01%)
Current stock: RHHBY